Description: Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada.
Home Page: www.biomarkdiagnostics.com
3851 Shell Road
Richmond,
BC
V6X 2W2
Canada
Phone:
604 370 0779
Officers
| Name | Title |
|---|---|
| Mr. Rashid Ahmed Maula Bux B.Sc., MBA | Founder, CEO, President & Director |
| Ms. Guoyu Huang MBA | Chief Financial Officer |
| Mr. Brian Kai-Ming Cheng B.Sc., M.Sc, M.Sc. | Chief Technical Officer & Independent Director |
| Dr. Jeff Haince Ph.D. | GM & Chief Scientific Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 83.5358 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |